As we approach the first week of February 2025, several major U.S. companies are set to release their earnings reports, providing critical insights into their financial health and future prospects.
Here’s a look at how each stock is currently performing and what to expect from their upcoming earnings.
Palantir Technologies has seen a remarkable surge in its stock price, soaring over 405% in the past year. Currently, it trades around $51.50, but analysts have mixed views on its valuation.
The company is expected to report earnings of $0.11 per share for Q4 2024, reflecting a 37.5% increase year-over-year.
Revenue projections stand at approximately $778.89 million, indicating a 28% increase from the previous year.
Despite its strong growth momentum and recent addition to the Nasdaq 100 index, some analysts express concerns about its valuation amid AI-related hype, with price targets suggesting potential downside.
Amazon is poised to report earnings after market close on February 6. Analysts expect the e-commerce giant to deliver an EPS of $1.54, driven by robust performance in its AWS cloud services and advertising sectors.
Currently trading around $140, Amazon’s stock has shown resilience, reflecting strong consumer demand and strategic investments in technology.
Disney will release its earnings report on February 5, with expectations centered on its streaming service performance and theme park recovery.
The stock is currently priced at approximately $90, facing challenges from increased competition in the streaming space. Analysts are particularly interested in subscriber growth for Disney+ and overall revenue trends.
Set to report on February 7, Apple is expected to post an EPS of $1.88. The stock is currently trading around $175, buoyed by strong iPhone sales and services revenue. Investors will be looking for updates on product launches and supply chain management as Apple continues to navigate a competitive market.
Tesla’s earnings report is also due on February 7, with anticipated EPS of $1.01. The stock is currently valued at around $250 and has experienced volatility due to production challenges and market competition. Investors are keenly watching for updates on delivery numbers and future production plans.
AstraZeneca will report earnings before market open on February 6, with expectations of an EPS of $1.46.
Currently trading at approximately $60, the pharmaceutical company is focusing on its oncology pipeline and COVID-19 vaccine sales as key drivers for growth.
This week’s earnings reports are set against a backdrop of cautious optimism in the market, with investors eager to gauge how these industry leaders are performing amidst economic uncertainties and evolving consumer behaviors.
In celebration of its 98th anniversary, 7‑Eleven is treating customers across the United States to…
Bitcoin has smashed through yet another milestone—soaring past $116,000 for the first time in history.…
Snack food giant Mondelēz Global LLC has issued a voluntary nationwide recall of several Ritz…
In a move that has become almost predictable in Elon Musk's corporate universe, X CEO…
The commercial vehicle market in 2025 presents fleet managers with complex decisions regarding whether to…
Global online marketplace Temu has launched its first local warehouse facility in South Africa, marking…